Changes in the secretion of insulin-like growth factor binding proteins -2 and -4 associated with the development of tamoxifen resistance and estrogen independence in human breast cancer cell lines

Cancer Letters

Volumn 139, Issue 2, 1999, Pages 121-127

  Maxwell, P ^a   Van Den Berg, H W ^a  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

Author keywords

Breast cancer; Insulin like growth factor; Insulin like growth factor binding proteins; Insulin like growth factor I receptor; Tamoxifen resistance

Indexed keywords

ESTROGEN; SOMATOMEDIN BINDING PROTEIN 2; SOMATOMEDIN BINDING PROTEIN 4; SOMATOMEDIN RECEPTOR; TAMOXIFEN;

ARTICLE; BREAST CANCER; CANCER CELL; CHEMOLUMINESCENCE; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNOBLOTTING; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION;

ANTINEOPLASTIC AGENTS, HORMONAL; BREAST NEOPLASMS; CHEMILUMINESCENT MEASUREMENTS; DRUG RESISTANCE, NEOPLASM; ESTROGEN ANTAGONISTS; ESTROGENS; HUMANS; IMMUNOBLOTTING; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 2; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 4; NEOPLASMS, HORMONE-DEPENDENT; SECRETORY RATE; TAMOXIFEN; TUMOR CELLS, CULTURED;

MINK CELL FOCUS-FORMING VIRUS;

EID: 0032960156     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(99)00009-9     Document Type: Article

References (23)

1. Boylan M., Vandenberg H.W., Lynch M. The anti-proliferative effect of suramin towards tamoxifen-sensitive and resistant human breast cancer cell lines in relation to expression of receptors for epidermal growth factor and insulin-like growth factor-I: growth stimulation in the presence of tamoxifen. Ann. Oncol. 9:1998;205-211.
2. Bronzert D.A., Greene G.L., Lippman M.E. Selection and characterisation of a breast cancer cell line resistant to the antiestrogen LY 117018. J. Endocrinol. 117:1985;1407-1409.
3. Cheung P.T, Smith E.P., Shimasaki S., Ling N., Chernausek S. Characterisation of insulin-like growth factor binding protein (IGFBP-4) produced by B104 rat neuronal cell line: chemical and biologic properties and differential synthesis by sublines. Endocrinology. 129:1991;1006-1015.
4. Clemmons D.R., Camacho-Hubner C., Coronado E., Osborne C.K. Insulin-like growth factor binding protein secretion by breast cancer cell lines: correlation with estrogen receptor status. Endocrinology. 127:1990;2679-2686.
5. Elgin R.G., Busby W.H., Clemmons D.R. An insulin-like growth factor (IGF) binding protein enhances the biological response to IGF-I. Proc. Natl. Acad. Sci. USA. 84:1987;3254-3258.
6. Figueroa J.A., Sharma J., Jackson J.G., McDermott M.J., Hilsenbeck S.G., Yee D. Recombinant insulin-like growth factor binding protein-I inhibits IGF-I, serum and estrogen dependent growth of MCF-7 human breast cancer cells. J. Cell. Physiol. 157:1993;229-236.
7. Figueroa J.A., Yee D. The insulin-like growth factor binding proteins (IGFBPs) in human breast cancer. Breast Cancer Res. Treat. 22:1992;81-90.
8. Fowlkes J.L., Serra D. A rapid, non-radioactive method for the detection of insulin-like growth factor binding proteins by Western ligand blotting. Endocrinology. 137:1996;5751-5754.
9. Kim H-S., Nagalla S.R., Oh Y., Wilson E., Roberts C.T., Rosenfeld R.G. Identification of a family of low-affinity insulin-like growth factor binding proteins (IGFBPs): characterisation of connective tissue growth factor as a member of the IGFBP superfamily. Proc. Natl. Acad. Sci. USA. 94:1997;12981-12986.
10. Jones J.I., Clemmons D.R. Insulin-like growth factors and their binding proteins: biological actions. Endocrine Rev. 16(1):1995;3-34.
11. McCotter D., Van Den Berg H.W., Boylan M., McKibben B. Changes in insulin-like growth factor-1 receptor expression and binding protein secretion associated with tamoxifen resistance and estrogen independence in human breast cancer cells in vitro. Cancer Lett. 99:1996;239-245.
12. Mohan S., Bautista C.M., Wergedal J., Baylink D.J. Isolation of an inhibitory insulin-like growth factor (IGF) binding protein from bone cell-conditioned medium: a potential local regulator of IGF action. Proc. Natl. Acad. Sci. USA. 86:1989;8338-8342.
13. Oh Y., Nagalla S.R., Yamanaka Y., Kim H.S., Wilson E., Rosenfeld R.G. Synthesis and characterisation of insulin-like growth factor binding protein (IGFBP)-7: recombinant human mac25 protein specifically binds IGF-I and -II. J. Biol. Chem. 271:1996;30322-30325.
14. Pratt S.E., Pollak M.N. Estrogen and anti-estrogen modulation of MCF-7 human breast-cancer cell proliferation is associated with specific alterations in accumulation of insulin-like growth factor binding proteins in conditioned media. Cancer Res. 53:1993;5193-5198.
15. Sheikh M.S., Shao Z.-M., Clemmons D.R., Leroith D., Roberts C.T., Fontana J.A. Identification of the insulin-like growth factor binding proteins-5 and -6 (IGFBP-5 and -6) in human breast cancer cells. Biochem. Biophys. Res. Commun. 183:1992;1003-1010.
16. Towbin H., Staehelin T., Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc. Natl. Acad. Sci. USA. 76:1979;4350-4354.
17. van den Berg H.W., Lynch M., Nelson J., Dickson G.R., Crockard A.D. Characterisation of a tamoxifen-resistant variant of the ZR-75-1 human breast cancer cell line (ZR-75-9a1) and stability of the resistant phenotype. Br. J. Cancer. 59:1989;522-526.
18. van den Berg H.W., Martin J., Lynch M. High progesterone receptor content in a variant of the ZR-75-1 human breast cancer cell line adapted to grow in oestrogen free conditions. Br. J. Cancer. 61:1990;504-507.
19. van den Berg H.W., Claffie D., Boylan M., McKillen J., Lynch M., McKibben B. Expression of receptors for epidermal growth factor and insulin-like growth factor-I by ZR-75-1 cells and variants is inversely related: the effect of steroid hormones on insulin-like growth factor-I receptor expression. Br. J. Cancer. 73:1996;477-481.
20. Yee D., Favoni R.E., Lippman M.E., Powell D.R. Identification of insulin-like growth factor binding proteins in breast cancer cells. Breast Cancer Res. Treat. 18:1991;3-10.
21. Yee D., Sharma J., Hilsenbeck G. Prognostic significance of insulin-like growth factor-binding protein expression in axillary lymph node-negative breast cancer. J. Natl. Cancer. Inst. 86:1994;1785-1789.
22. Zapf J. Physiological role of the insulin-like growth factor binding proteins. Eur. J. Endocrinol. 132:1995;645-654.
23. Zapf J., Kiefer M., Merryweather J., Masiarz F., Bauer D., Born W., Fischer J.A., Froesch E.R. Isolation from adult human serum of four insulin-like growth factor (IGF) binding proteins and molecular cloning of one of them that is increased by IGF-I administration and in extrahepatic tumor hypoglycemia. J. Biol. Chem. 265:1990;14892-14898.